Sports minister says RUSADA doping inspectors started testing athletesSport July 25, 17:25
Arctic shelf development tops agenda of Murmansk international business weekBusiness & Economy July 25, 17:08
Trump backs investigation into Kiev’s meddling attempts to sabotage his election campaignWorld July 25, 16:57
Erdogan announces deal with Russia on S-400 air defense missile systemsMilitary & Defense July 25, 16:16
Austria concerned about US attempts to achieve own economic ambitions via Russia sanctionsBusiness & Economy July 25, 15:41
Russia may appeal ECHR’s decision on compensation for defendant in Nemtsov murder caseSociety & Culture July 25, 15:23
Moldovan president, Russian envoy to hash over bilateral ties and breakaway TransnistriaRussian Politics & Diplomacy July 25, 14:43
US will either have to put up with North Korea’s nuclear weapons or use force — expertWorld July 25, 14:33
Kremlin refrains from comments on media allegations about Tillerson’s possible resignationRussian Politics & Diplomacy July 25, 14:03
UNITED NATIONS, November 14. /TASS/. If the tests of experimental vaccines against the Ebola virus are successful, they will be available next year, UN Secretary-General’s special envoy David Nabarro said on Thursday. According to him, there are two highly promising potential vaccines. Sierra Leone’s Permanent Representative to the United Nations Vandi Chidi Minah told reporters that he expected “good news” about the results of the tests by the end of the current year.
According to the World Health Organization (WHO), the number of fatalities of the fever epidemic outbreak in West Africa has exceeded 5,100 people and 14,100 people have been infected. The situation is the most serious in Guinea, Liberia and Sierra Leone.
A number of countries are actively developing the Ebola vaccine. The UK, Japan, Russia and China have made progress in this area. On Wednesday, the international humanitarian organization Doctors Without Borders announced it would hold in December the vaccine testing in three medical centres in West Africa. Russia and China this week has allocated tens of millions of dollars for the development of the antiviral drugs.